Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era.
Initial enthusiasm for balloon aortic valvuloplasty (BAV) as an alternative to surgical aortic valve replacement waned because of the perceived failure of the procedure to alter the natural history of calcific severe aortic valve stenosis (AS) and significant initial procedural morbidity. Despite technical and procedural advances, BAV has been reserved as a palliative procedure for patients who cannot undergo valve replacement or as a bridge to surgery in hemodynamically unstable patients. This article reviews the indications, technical aspects, and outcomes of BAV for calcific AS and discusses the current role of BAV in the era of transcatheter aortic valve replacement.